Skip to main content
. 2020 Sep 24;21(15):1065–1072. doi: 10.2217/pgs-2020-0065

Table 1. . Demographic information on the CAUS and pharmacogenomic schizophrenia/schizoaffective disorder patient samples included in the study.

Samples CAUS PGx
n (TD+/TD-) 148 (63/85) 58 (19/39)
Sex (male/female) 97/51 45/13
Mean age in years (standard deviation) 39.01 (10.50) 41.10 (13.42)
CYP2D6 metabolizer phenotype (PM/IM/EM/UM) 6/11/123/8 4/6/48/0

EM: Extensive metabolizer; IM: Intermediate metabolizer; PGx: Pharmacogenomic; PM: Poor metabolizer; TD: Tardive dyskinesia; UM: Ultra-rapid metabolizer.